US 11826327
Treatment for interstitial lung disease
granted A61KA61K31/192A61K31/5575
Quick answer
US patent 11826327 (Treatment for interstitial lung disease) held by United Therapeutics Corporation expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/192, A61K31/5575, A61K9/0075, A61K9/0078